Full video transcriptClick to expand
Auto-generated transcript of @kellyramirez30's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.
- 0:00I'm gonna take you step by step, exactly what I do.
- 0:02The thing is to be able to wash your hands.
- 0:05Now, all I'm gonna do is remove the lid.
- 0:07This is completely optional.
- 0:08I like to grab some alcohol and I don't have a cotton pad.
- 0:12I'm just gonna grab a paper towel and pour.
- 0:14Ooh, that was a lot.
- 0:15And you'll just kind of want to rub around,
- 0:19necessarily on top because that's where the medication
- 0:21is gonna be coming out of.
- 0:23And then with this one, and I'm just gonna grab
- 0:26one of these, you do also have the option
- 0:28to put any gloves on, but I just feel like
- 0:30that's a little bit extra.
- 0:32Once you're ready, you're just gonna pull this off
- 0:34and then just twist it.
- 0:36You have different options where you can take it.
- 0:38Like I said, your stomach, your arm, or your thighs.
- 0:41Usually those are the three that I know
- 0:43that are the most common.
- 0:45Now, I'm gonna personally show you the one spot
- 0:48that most people don't like to do it on.
- 0:50It's their arm.
- 0:51I'm actually gonna give you a hack
- 0:53that I recently just saw on TikTok.
- 0:55I saw this girl, she put a hair clip.
- 0:58The first thing that I'm gonna end up doing
- 1:00is just grab a paper towel with some alcohol,
- 1:03and then whatever area I'm gonna do it on,
- 1:06pull this orange part, that's where the needle's gonna be at.
- 1:08Going to twist depending on what dose.
- 1:11Mine is a 0.6, so you're going to push in order
- 1:15to inject the medication.
- 1:17Okay.
- 1:18One, two, three, four, five, six, seven, eight.
- 1:20Put the clip, the orange part on, and I will twist this
- 1:25and then stick back.
- 1:27This is super crucial.
- 1:28Please do not throw away your needles in the trash.
- 1:31Usually you can go to a drug store,
- 1:33you can go online and order like a special box.
- 1:36But let's say that you don't have that
- 1:38or you just don't have money to get one,
- 1:40you can just put it in as a block baggie
- 1:42and drop it off at your nearest pharmacy.
- 1:44Sometimes there are certain places
- 1:46where you can drop off needles
- 1:47and unneeded medication that you don't use anymore.
- 1:49That's pretty much it.
- 1:50I'll see you again tomorrow.
Saxenda injection technique: What TikTok gets right and wrong
Quick answer
Saxenda (liraglutide 3 mg) is a daily subcutaneous GLP-1 receptor agonist approved by the FDA for chronic weight management, administered via a prefilled multi-dose pen with disposable needles. The creator demonstrates the 0.6 mg starting dose, which is the first step in a mandatory five-week titration schedule before reaching the 3 mg maintenance dose. Proper subcutaneous injection technique, including site rotation and appropriate dwell time, directly affects drug absorption consistency and local tissue health over the course of treatment.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For Saxenda injection technique: What TikTok gets right and wrong, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference
A broad meta-analysis anchor for GLP-1 weight-loss effect and class-level comparisons.
PubMed
Discontinuing glucagon-like peptide-1 receptor agonists and body habitus
Used for pages discussing stopping therapy, weight regain, and long-term planning.
PubMed
The human peptide GHK-Cu in prevention of oxidative stress and degenerative conditions of aging
Anchor review for copper peptide gene-expression and tissue-repair claims.
PubMed
Effects of glycyl-histidyl-lysine-Cu on wound healing
Search-backed PubMed trail for wound-healing claims where specific topical versus injectable context matters.
PubMed
Video claim decision path
Turn the claim into a safer next question
Direct answer
Saxenda injection technique: What TikTok gets right and wrong should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.
Evidence check
Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.
Safety check
A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.
Next step
If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.
Helpful context before the funnel
Page-specific review note
What this exact clip is really saying
This FormBlends review is specific to "Saxenda injection technique: What TikTok gets right and wrong" from Kelly's • Lifestyle • GLP1. We read the clip as a GLP-1 social video fact-checks claim about GLP-1 social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Saxenda (liraglutide 3 mg) is a daily subcutaneous GLP-1 receptor agonist approved by the FDA for chronic weight management, administered via a prefilled multi-dose pen with disposable needles.
The reason this review is not generic is the source wording and the canonical claim label "glp1 glp 1 shot day this is how i do mine saxenda glp1community g." In this clip, the useful excerpt is: "I'm gonna take you step by step, exactly what I do." That wording changes the review because it points to GLP-1 social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.
The source trail for this page is checked against Efficacy of GLP-1 Receptor Agonists on Weight Loss, BMI, and Waist Circumference (2025), Discontinuing glucagon-like peptide-1 receptor agonists and body habitus (2025), and Effect of glucagon-like peptide-1 receptor agonists and co-agonists on body composition (2025), plus the creator's own wording. GLP-1 social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.
Claim verdict
The useful answer behind this video
This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.
Claim being checked
Saxenda (liraglutide 3 mg) is a daily subcutaneous GLP-1 receptor agonist approved by the FDA for chronic weight management, administered via a prefilled multi-dose pen with disposable needles.
FormBlends verdict
GLP-1 social video fact-checks evidence, safety, and patient-fit context
Evidence strength
Source-backed review with clinical or regulatory citations.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- Saxenda (liraglutide 3 mg) is a daily subcutaneous GLP-1 receptor agonist approved by the FDA for chronic weight management, administered via a prefilled multi-dose pen with disposable needles. The creator demonstrates the 0.6 mg starting dose, which is the first step in a mandatory five-week titration schedule before reaching the 3 mg maintenance dose. Proper subcutaneous injection technique, including site rotation and appropriate dwell time, directly affects drug absorption consistency and local tissue health over the course of treatment.
- Saxenda's instructions for use specify alcohol prep on the skin injection site only, not on the pen needle tip. Swabbing the needle with a paper towel introduces contamination risk.
- A dwell time of 6-8 seconds after injection is supported by evidence. Berard et al. (2015, Diabetes Technology and Therapeutics) showed reduced leakage with longer needle hold times for subcutaneous injections.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- Saxenda's instructions for use specify alcohol prep on the skin injection site only, not on the pen needle tip. Swabbing the needle with a paper towel introduces contamination risk.
- A dwell time of 6-8 seconds after injection is supported by evidence. Berard et al. (2015, Diabetes Technology and Therapeutics) showed reduced leakage with longer needle hold times for subcutaneous injections.
- Site rotation is not mentioned in this video but is clinically important. Frid et al. (2021, Diabetes Care) found lipohypertrophy in up to 41% of patients who did not rotate subcutaneous injection sites.
- The 0.6 mg dose shown is the Saxenda starting dose only. The approved maintenance dose is 3 mg daily, reached through a five-week titration schedule set by a prescriber.
- The FDA recommends FDA-cleared sharps containers for needle disposal. While pharmacy take-back programs exist, a sealed bag is not an FDA-approved equivalent and should be treated as a last resort.
- The upper arm, abdomen, and thigh are all FDA-label-approved injection sites for liraglutide. All three sites are clinically valid as confirmed in Saxenda's prescribing information.
- GLP-1 tutorials on social media consistently underreport site rotation guidance. Patients relying solely on peer content for injection technique are likely missing this step.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.
What did @kellyramirez30 actually say?
Kelly walked her 18K viewers through her personal Saxenda (liraglutide) self-injection routine, covering hand washing, alcohol swabbing, needle attachment, site selection, and sharps disposal. She recommended the stomach, arm, or thigh as injection sites, showed a hair clip trick to pinch arm skin solo, counted to eight seconds after injecting, and told viewers not to throw needles in the trash. She added a disclaimer that she is not a doctor, which matters here.
The video reads as practical and well-intentioned. Most of what she demonstrated tracks with standard subcutaneous injection technique. A few specifics, however, deserve closer scrutiny, particularly around alcohol prep, gloves, and whether her disposal advice covers all situations adequately.
Does the science back this up?
Mostly yes, with some caveats. The core injection mechanics she demonstrated, pulling the cap, attaching the needle, pinching the skin, injecting slowly, and counting seconds before withdrawing, are consistent with Novo Nordisk's prescribing information for Saxenda and standard subcutaneous injection guidance from nursing literature.
The eight-second hold she counted out is actually supported. A 2015 study by Berard et al. in Diabetes Technology and Therapeutics found that longer needle dwell time (at least six seconds) reduced insulin leakage at the injection site for subcutaneous injections. While that research focused on insulin, the pharmacokinetic logic applies to other subcutaneous peptides like liraglutide. The three recommended sites, abdomen, thigh, and upper arm, are exactly what Saxenda's label specifies. Site rotation to avoid lipohypertrophy is not mentioned in the video, which is a genuine gap.
What did they get wrong (or right)?
The alcohol prep method is where things get sloppy. Kelly poured alcohol directly onto a paper towel and rubbed it over the pen tip, saying you want to rub "necessarily on top because that's where the medication is gonna be coming out of." That is backwards. You swab the injection site on your skin, not the pen needle tip. Rubbing alcohol on the needle itself before injection is not part of standard technique and could theoretically introduce lint or fiber contamination. The Saxenda instructions for use do not include this step.
On gloves: she called them "a little bit extra." For home self-injection in a non-clinical setting, she is not wrong. The CDC's guidance on home injection technique does not require gloves for self-administered subcutaneous medications. Credit where it is due.
Her sharps disposal advice is directionally correct. The FDA recommends FDA-cleared sharps disposal containers, and she correctly noted that pharmacies often accept them. The suggestion to use a "block baggie" as an interim solution is not FDA-endorsed but reflects real-world guidance from some harm reduction and waste programs. It is worth stating plainly: a sealed, puncture-resistant container is the correct standard.
What should you actually know?
If you are self-injecting a GLP-1 medication like Saxenda, the things that actually matter clinically are site rotation, proper subcutaneous depth, needle length appropriateness for your body composition, and consistent timing relative to meals and your weekly or daily schedule. Liraglutide is a daily injection, and consistency affects tolerability.
A 2021 review by Frid et al. in Diabetes Care examined injection technique errors across thousands of patients and found that lipohypertrophy (hardened fatty tissue from repeated injections in the same spot) affected up to 41% of insulin users who did not rotate sites. The same risk applies to any subcutaneous peptide. Kelly does not mention rotation at all, and for a 18K-view tutorial, that omission has real consequences.
Dose escalation for Saxenda follows a specific titration schedule set by your prescriber. The 0.6 mg dose Kelly mentions is the starting dose, not a maintenance dose. Viewers watching this should not interpret her dose as a target or recommendation for their own use.
The bottom line on this video
Kelly's tutorial is more accurate than harmful, which puts it ahead of a lot of GLP-1 content on TikTok. She got the mechanics right, she included a disclaimer, and her disposal messaging is mostly sound. The alcohol swab error is a genuine technique mistake that 18,000 people may now replicate incorrectly. The absence of any mention of site rotation is a real gap in an otherwise practical video. The hair clip arm-pinch hack is creative and not clinically problematic. If you are starting a GLP-1 injection for the first time, this video is a reasonable visual reference, but read your medication's actual instructions for use and confirm technique with your prescriber or pharmacist.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Kelly’s • Lifestyle • GLP1 · TikTok creator
18.0K views on this video
GLP-1 Shot Day 💉 This Is How I Do Mine! #saxenda #glp1community #glp1 #saxendajourney Disclaimer: I’m not a doctor! This is just how I take my shot. Please consult your doctor for proper instructions 💬
Frequently asked questions
Quick answers based on this video and our medical team review.
What does the video say about saxenda's instructions for use specify alcohol prep on the skin?
Saxenda's instructions for use specify alcohol prep on the skin injection site only, not on the pen needle tip. Swabbing the needle with a paper towel introduces contamination risk.
What does the video say about a dwell time of 6-8 seconds after injection?
A dwell time of 6-8 seconds after injection is supported by evidence. Berard et al. (2015, Diabetes Technology and Therapeutics) showed reduced leakage with longer needle hold times for subcutaneous injections.
What does the video say about site rotation?
Site rotation is not mentioned in this video but is clinically important. Frid et al. (2021, Diabetes Care) found lipohypertrophy in up to 41% of patients who did not rotate subcutaneous injection sites.
What does the video say about the 0.6 mg dose shown?
The 0.6 mg dose shown is the Saxenda starting dose only. The approved maintenance dose is 3 mg daily, reached through a five-week titration schedule set by a prescriber.
What does the video say about the fda recommends fda-cleared sharps containers for needle disposal. while?
The FDA recommends FDA-cleared sharps containers for needle disposal. While pharmacy take-back programs exist, a sealed bag is not an FDA-approved equivalent and should be treated as a last resort.
What does the video say about the upper arm, abdomen,?
The upper arm, abdomen, and thigh are all FDA-label-approved injection sites for liraglutide. All three sites are clinically valid as confirmed in Saxenda's prescribing information.
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Kelly’s • Lifestyle • GLP1, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.